Bausch Health Companies Inc (BHC) concluded trading on Thursday at a closing price of $7.46, with 8.09 million shares of worth about $60.35 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 25.17% during that period and on January 30, 2025 the price saw a loss of about -0.13%. Currently the company’s common shares owned by public are about 365.24M shares, out of which, 290.99M shares are available for trading.
Stock saw a price change of -4.48% in past 5 days and over the past one month there was a price change of -2.48%. Year-to-date (YTD), BHC shares are showing a performance of -7.44% which decreased to -10.44% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.96 but also hit the highest price of $11.46 during that period. The average intraday trading volume for Bausch Health Companies Inc shares is 2.11 million. The stock is currently trading -2.94% below its 20-day simple moving average (SMA20), while that difference is down -4.65% for SMA50 and it goes to 1.15% higher than SMA200.
Bausch Health Companies Inc (NYSE: BHC) currently have 365.24M outstanding shares and institutions hold larger chunk of about 61.34% of that.
The stock has a current market capitalization of $2.74B and its 3Y-monthly beta is at 0.68. It has posted earnings per share of -$0.48 in the same period. It has Quick Ratio of 0.82. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BHC, volatility over the week remained 3.56% while standing at 3.77% over the month.
Stock’s fiscal year EPS is expected to rise by 7.81% while it is estimated to increase by 13.00% in next year. EPS is likely to shrink at an annualized rate of 11.94% for next 5-years, compared to annual growth of 32.76% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on August 02, 2024 offering an Underweight rating for the stock and assigned a target price range of between $9 and $3 to it. Coverage by Raymond James stated Bausch Health Companies Inc (BHC) stock as a Mkt perform in their note to investors on July 10, 2024, suggesting a price target of $8 for the stock. Stock get a Hold rating from Truist on July 29, 2022.
